-
Something wrong with this record ?
The relationship between ECG predictors of cardiac resynchronization therapy benefit
J. Halamek, P. Leinveber, I. Viscor, R. Smisek, F. Plesinger, V. Vondra, J. Lipoldova, M. Matejkova, P. Jurak,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-10-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-01-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Action Potentials MeSH
- Bundle-Branch Block physiopathology therapy MeSH
- Electric Countershock MeSH
- Electrocardiography methods standards MeSH
- Ventricular Function, Left MeSH
- Humans MeSH
- Predictive Value of Tests MeSH
- Cardiac Resynchronization Therapy Devices standards MeSH
- Heart Rate MeSH
- Cardiac Resynchronization Therapy methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
INTRODUCTION: Cardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality and improves cardiac function in patients with left bundle branch block (LBBB). However, about 30% of patients passing the current criteria do not benefit or benefit only a little from CRT. Three predictors of benefit based on different ECG properties were compared: 1) "strict" left bundle branch block classification (SLBBB); 2) QRS area; 3) ventricular electrical delay (VED) which defines the septal-lateral conduction delay. These predictors have never been analyzed concurrently. We analyzed the relationship between them on a subset of 602 records from the MADIT-CRT trial. METHODS & RESULTS: SLBBB classification was performed by two experts; QRS area and VED were computed fully automatically. High-frequency QRS (HFQRS) maps were used to inspect conduction abnormalities. The correlation between SLBBB and other predictors was R = 0.613, 0.523 and 0.390 for VED, QRS area in Z lead, and QRS duration, respectively. Scatter plots were used to pick up disagreement between the predictors. The majority of SLBBB subjects- 295 of 330 (89%)-are supposed to respond positively to CRT according to the VED and QRS area, though 93 of 272 (34%) non-SLBBB should also benefit from CRT according to the VED and QRS area. CONCLUSION: SLBBB classification is limited by the proper setting of cut-off values. In addition, it is too "strict" and excludes patients that may benefit from CRT therapy. QRS area and VED are clearly defined parameters. They may be used to optimize biventricular stimulation. Detailed analysis of conduction irregularities with CRT optimization should be based on HFQRS maps.
Institute of Scientific Instruments of the Czech Academy of Sciences Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006303
- 003
- CZ-PrNML
- 005
- 20200518132528.0
- 007
- ta
- 008
- 200511s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0217097 $2 doi
- 035 __
- $a (PubMed)31150418
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Halamek, Josef $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 245 14
- $a The relationship between ECG predictors of cardiac resynchronization therapy benefit / $c J. Halamek, P. Leinveber, I. Viscor, R. Smisek, F. Plesinger, V. Vondra, J. Lipoldova, M. Matejkova, P. Jurak,
- 520 9_
- $a INTRODUCTION: Cardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality and improves cardiac function in patients with left bundle branch block (LBBB). However, about 30% of patients passing the current criteria do not benefit or benefit only a little from CRT. Three predictors of benefit based on different ECG properties were compared: 1) "strict" left bundle branch block classification (SLBBB); 2) QRS area; 3) ventricular electrical delay (VED) which defines the septal-lateral conduction delay. These predictors have never been analyzed concurrently. We analyzed the relationship between them on a subset of 602 records from the MADIT-CRT trial. METHODS & RESULTS: SLBBB classification was performed by two experts; QRS area and VED were computed fully automatically. High-frequency QRS (HFQRS) maps were used to inspect conduction abnormalities. The correlation between SLBBB and other predictors was R = 0.613, 0.523 and 0.390 for VED, QRS area in Z lead, and QRS duration, respectively. Scatter plots were used to pick up disagreement between the predictors. The majority of SLBBB subjects- 295 of 330 (89%)-are supposed to respond positively to CRT according to the VED and QRS area, though 93 of 272 (34%) non-SLBBB should also benefit from CRT according to the VED and QRS area. CONCLUSION: SLBBB classification is limited by the proper setting of cut-off values. In addition, it is too "strict" and excludes patients that may benefit from CRT therapy. QRS area and VED are clearly defined parameters. They may be used to optimize biventricular stimulation. Detailed analysis of conduction irregularities with CRT optimization should be based on HFQRS maps.
- 650 _2
- $a akční potenciály $7 D000200
- 650 _2
- $a blokáda Tawarova raménka $x patofyziologie $x terapie $7 D002037
- 650 _2
- $a srdeční resynchronizační terapie $x metody $7 D058406
- 650 _2
- $a prostředky srdeční resynchronizační terapie $x normy $7 D058409
- 650 _2
- $a elektrická defibrilace $7 D004554
- 650 _2
- $a elektrokardiografie $x metody $x normy $7 D004562
- 650 _2
- $a srdeční frekvence $7 D006339
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a funkce levé komory srdeční $7 D016277
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Leinveber, Pavel $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Viscor, Ivo $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Smisek, Radovan $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Plesinger, Filip $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Vondra, Vlastimil $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Lipoldova, Jolana $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Matejkova, Magdalena $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Jurak, Pavel $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 5 (2019), s. e0217097
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31150418 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132527 $b ABA008
- 999 __
- $a ok $b bmc $g 1525161 $s 1096359
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 14 $c 5 $d e0217097 $e 20190531 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20200511